Medical Advocates for Social Justice

   Medical Advocates for Social Justice

 Kaletra Library Service 
Conference Abstracts and Posters
   

 


 

 		4th International Workshop on the Clinical
Pharmacology of HIV Therapy
Cannes, France



 March 27-29, 2003		  
 
Main New/Newsworthy  Kaletra Conference Data Home
Last Update:  February 21, 2007  (ADDITIONAL POSTER AND ABSTRACTS WILL ADDED THROUGHOUT JUNE)
 Documents identified with this icon  are in Portable Document Format (PDF) and require the
 Adobe Acrobat Reader 5 .
Some of these documents may take a few minutes to download.
Drug Data
Protease Inhibitors: General Data
 
 

PDF CONFERENCE POSTER
Inhibitory Quotient (IQ) of Protease Inhibitors (PIs) Using a Standardized
Determination of IC50

Stevens RC,  Kakuda TN,  Bertz R, et al
Poster

 
PDF CONFERENCE POSTER
The effect of antiretroviral protease inhibitors on P-gp expression in CD4 and CD8
subpopulations of lymphocytes.
Ford J, Chandler B, Khoo SH, Back DJ , et al.
 Poster


Drug-Specific Data

Capravirine

  CONFERENCE PDF POSTER
Integrated Adherence, Pharmacokinetic, and Pharmacodynamic Modeling to
Design a Dose-Ranging Study of Capravirine with Kaletra in Treatment-
Experienced Patients.
P Hawley, M Amantea, B. Poland. et al
 Poster
 
CONFERENCE PDF POSTER
Pharmacokinetic Model of Capravirine (CPV), a Novel Non-Nucleoside Reverse
Transcriptase Inhibitor (NNRTI), Co-Administered with Kaletra (KLT) in Healthy
and HIV-Infected Subjects.
M Amantea, S. Raber, R. Pesano, et al.
 Poster

Didanosine

  CONFERENCE PDF POSTER
Pharmacokinetic Evaluation of Reduced Doses of Didanosine Enteric
Coated Capsules (ddI EC) in Combination with Tenofovir Disoproxil
Fumarate  (TDF) and Food for a Once-Daily Antiretroviral Regimen.
S Kaul , B Damle , K Bassi,  et al
Poster

Efavirenz
 
 
CONFERENCE PDF POSTER
 Therapeutic Drug Monitoring of Efavirenz in HIV-infected patients treated by
Sustiva associated or not with ritonavir.
S Faroux,  M Berhoune ,  H Sauvageon-Martre, et al
 Poster

Efavirenz and Nevirapine concentration-effect relationships in HIV infected patients
pharmacologically followed by routine therapeutic drug monitoring (TDM)
Garraffo R, Lavrut T, Pierre B, et al.
Abstract

Indinavir
 
 

CONFERENCE PDF POSTER
Steady-State Pharmacokinetics and Tolerability of Indinavir When Co-Administered
With Lopinavir/r in Antiretroviral-Experienced Subjects.
A Tseng, E Phillips, T Antoniou, et al
 Poster
 
CONFERENCE PDF POSTER
 MDR1 genotypes associated with antiviral dynamics and indinavir (IDV) disposition
in HIV-infected patients
PL Anderson, J Lamba, E Schuetz, CV Fletcher.
 Poster

Lopinavir
 
 
CONFERENCE POWER-POINT POSTER
 Lopinavir plasma concentrations and lipid elevation patterns in patients on
lopinavir/ritonavir-containing regimens.
M Boffito, S Bonora, A Sinicco, et al.
Poster
 

CONFERENCE PDF POSTER
 Effect of LPV trough level on the biological markers of cardiovascular risk in
LPV/r treated HIV infected patients
 Valerio L., Fontas E., Garraffo R., et al
 Abstract    Poster

 

CONFERENCE PDF POSTER
 Simplifying Therapeutic Drug Monitoring for Twice Daily Regimens of Kaletra
C Alexander J. Montaner,  J. Asselin et al
 Poster

 

Lack of drug-drug interaction between lopinavir and  saquinavir based
on their trough plasma concentrations  in highly HIV-experienced
patients treated with Kaletra and Invirase.  
JM Poirier , O Zouai , JL Meynard , et al
 Abstract
 

Nelfinavir
 
  CONFERENCE PDF POSTER
Improved Gastrointestinal (GI) Tolerability of Roche Nelfinavir 625 mg Film-Coated
Tablets in Comparison with Nelfinavir 250 mg Film-Coated Tablets (Viracept)
B Kaeser, D-J Akintola, A Saifulanwar,et al
 Poster

Nevirapine
 
  CONFERENCE PDF POSTER
 Quality-Control Analysis of Generic Nevirapine Formulations in the
Developing World: An Initial Report (Note These results were also
published as a research letter in the May 28 issue of JAMA)
Penzak SR, Acosta EP, J Tavel JA, et al
 Poster

CONFERENCE PDF POSTER
Relationship between nevirapine plasma concentration and abnormal liver function
tests in a cohort of heterogeneous HIV+ patients
Almond L, Boffito M, Hoggard P
 Poster

Saquinavir
 
  CONFERENCE PDF POSTER
Pharmacokinetics of Saquinavir hard gel (Invirase) when combined with Atazanavir
D Prelutsky, P Salvato, R Falcon. et al
 Poster

Therapeutic Drug Monitoring

  CONFERENCE PDF POSTER
HIV Drug Interaction and Antiretroviral (ARV) Therapeutic Drug Monitoring (TDM) Registry:
Attaining Compliance With Clinical Laboratory Improvement Act (CLIA) and the Health
Insurance Portability and Accountability Act (HIPPA)
J Slish, LCatanzaro, L Esch, et al.
Poster
 
CONFERENCE PDF POSTER
Therapeutic Drug Monitoring of Efavirenz in HIV-infected patients treated by Sustiva associated
or not with ritonavir.
S Faroux,  M Berhoune ,  H Sauvageon-Martre, et al
 Poster

Top od the Page

Main New/Newsworthy  Kaletra Conference Data Home

4th International Workshop on the Clinical Pharmacology of HIV Therapy
 Kaletra Posters and Abstracts
A Medical Advocates for Social Justice Update